Related Experiment Video

Updated: Mar 26, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

16.5K

Current treatment options for hepatitis C patients co-infected with HIV

Jürgen Kurt Rockstroh1,2, W David Hardy3

  • 1a Department of Medicine I , Bonn University Hospital , Bonn , Germany.

Expert Review of Gastroenterology & Hepatology
|January 23, 2016
PubMed

Insights

Direct-acting antivirals (DAAs) have revolutionized hepatitis C virus (HCV) treatment for patients with HIV/HCV co-infection, achieving cure rates over 95%. Guidelines now treat these patients the same as HCV mono-infected individuals.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Antiviral Therapy

Background:

  • Hepatitis C virus (HCV) infection poses significant health risks, particularly for individuals with HIV/HCV co-infection.
  • Direct-acting antivirals (DAAs) represent a major advancement in HCV treatment.
  • Historically, HIV/HCV co-infected patients had different treatment considerations compared to HCV mono-infected individuals.

Purpose of the Study:

  • To review the current landscape of HCV therapy for HIV/HCV co-infected patients.
  • To highlight the impact of DAAs on HCV treatment outcomes in this population.
  • To emphasize the importance of considering drug interactions and hepatic decompensation risk.

Main Methods:

  • Review of current treatment guidelines and clinical data.
  • Analysis of DAA efficacy and safety in HIV/HCV co-infected patients.
  • Evaluation of drug-drug interactions between antiretroviral and antiviral agents.

Main Results:

  • HCV cure rates with DAAs are now comparable (>95%) between HCV mono-infected and HIV/HCV co-infected patients.
  • Current guidelines do not differentiate treatment indications or DAA choices based on HIV co-infection status.
  • Drug interactions between HIV and HCV medications require careful pre-treatment assessment.

Conclusions:

  • Modern DAA therapy has transformed HCV treatment, offering high cure rates for HIV/HCV co-infected individuals.
  • HIV/HCV co-infected patients remain a priority for DAA therapy due to their elevated risk of hepatic decompensation.
  • Careful management of potential drug interactions is crucial for successful HCV treatment in this population.

Keywords:
DAAHIVHepatitis Cantiretroviral therapycirrhosisdrug-interaction

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.5K
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

3.0K

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
34
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.5K
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
17
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
340
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
475
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.6K